Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Pharmexcil
Pharmexcil
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
N4 Pharma and SRI to target and treat previously unreachable human cells
The companies will collaborate to perform research to conjugate SRI’s MGS system to Nuvec to increase intracellular delivery to specific target cells.
Berry Global invests to increase production capacity for healthcare products
Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Contract manufacturing in India grows at 20%
SMEs predicted to be main beneficiaries of this growth
India calls off EU trade talks
Action reflects disappointment at EU ban on 700 Indian-made generics
Pharmaceutical
India and China set to dominate biosimilars market
Annual growth rate for biosimilars in India and China could reach 30% in 2014-18
Regulatory obstacles hinder Indian pharma exports to Vietnam
Companies 'red listed' by Vietnamese drug regulatory authority for regulatory non-compliance
Indian pharma exports could miss growth target
Delays in regulatory approvals in North America could halve expected growth rate
Pharmaceutical
Indian pharma to target eastern Europe
Delegation set to promote generics in Hungary, Czech Republic and Romania
Finance
India pharma exports to touch $25bn by 2018
Ability to supply Argentina a major boost to export growth
Subscribe now